Ropes-Steered Lilly To Buy Goodwin-Led Merida For $2.9B
Eli Lilly and Co., advised by Ropes & Gray LLP, said Monday that it has agreed to pay up to $2.875 billion in cash to purchase autoimmune- and allergic disease-focused biotech...To view the full article, register now.
Already a subscriber? Click here to view full article